Group A and C Meningococcal Polysaccharide Vaccine (Yunnan Center for Disease Control and Prevention)

A、C群脑膜炎球菌多糖疫苗(云南省疾病预防控制中心)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup A and C Meningococcal Polysaccharide Vaccine (Yunnan Center for Disease Control and Prevention)

Drug Alias NameMeningococcal group A, C bivalent polysaccharide conjugate vaccine (Yunnan Center for Disease Control and Prevention)

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Conjugated vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningococcal InfectionsMeningitis, Meningococcal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesYunnan Center for Disease Control and Prevention

China Registration ClassN/A

Develop Information

Active CompaniesYunnan Center for Disease Control and Prevention

Inactive CompaniesN/A

Active IndicationsMeningococcal Infections

Inactive IndicationsMeningitis, Meningococcal

Other Information

ATC CodeN/A